Methylene Blue: An Old Drug with New Potential for

Methylene Blue: An Old Drug with New Potential for Brain Health

Methylene blue (MB) is one of the oldest synthetic drugs known to humanity. First synthesised in 1876 as a textile dye, it quickly became a medical tool — used to treat malaria before chloroquine was invented. Today, researchers are investigating methylene blue's potential as a nootropic, mitochondrial support agent, and even as a preventive tool against neurodegenerative diseases.

This guide is for those who have heard about methylene blue's nootropic potential and want to know what is proven, what is speculative, and how to use it safely.

TL;DR

Methylene blue is an alternative electron carrier in the mitochondrial electron transport chain
At low doses (0.5–2 mg/kg) it improves mitochondrial efficiency and reduces oxidative stress
Animal studies show significant memory and learning improvements (Rojas et al., 2012)
Human studies are preliminary but promising — especially for attention and short-term memory
High doses are toxic — the dose-response curve is U-shaped
This is NOT an ordinary supplement — requires pharmaceutical-grade product

Why methylene blue is different

Most nootropics work at the neurotransmitter level — boosting dopamine, influencing acetylcholine, or modulating GABA. Methylene blue is different. It works in the cell's energy centre — the mitochondria — and affects fundamental cellular energy production.

This means its potential impact is not limited to the brain. Every cell that needs energy (which is every cell) could theoretically benefit. But the most convincing research so far is in the neurological context.

How methylene blue works

Mitochondrial electron transport

Mitochondria run the electron transport chain (ETC), which produces ATP — the universal energy currency of cells. Methylene blue acts as an alternative electron carrier — it can accept electrons from Complex I and deliver them to Complex IV, bypassing damaged or inefficient intermediary steps (Rojas et al., 2012).

Practical consequence: even if mitochondria have been damaged by age, stress, or toxins, methylene blue can help them produce ATP more efficiently.

Oxidative stress reduction

Paradoxically, methylene blue acts as an antioxidant at low doses, despite being chemically an oxidising agent. This happens because a low dose reduces electron leakage from mitochondria, which in turn reduces free radical production (Xiong et al., 2017).

Neurotransmitters

Methylene blue inhibits monoamine oxidase (MAO) — the enzyme that breaks down serotonin, dopamine, and noradrenaline. This mechanism is similar to some antidepressants, but with a much weaker effect at standard nootropic doses (Rodriguez et al., 2016).

What the research shows

Memory and learning (animal studies)

Rojas et al. (2012) demonstrated in mice that low-dose methylene blue improved memory consolidation and spatial learning. The effect was dose-dependent — too high a dose reversed the benefit.

Bruchey & Bhatt (2010) found that methylene blue enhanced fear extinction memory in rats — relevant to PTSD research.

Human studies

Rodriguez et al. (2016) conducted a placebo-controlled study in healthy volunteers. A single low dose (0.5 mg/kg) of methylene blue increased brain activity measured by fMRI during attention and memory tasks. Short-term memory scores improved significantly.

Oz et al. (2011) investigated methylene blue's effect on brain metabolism using MRI spectroscopy and found it increased cerebral blood supply and brain energy consumption.

Neurodegenerative diseases

Preliminary studies suggest potential in the context of Alzheimer's disease and other neurodegenerative conditions, but clinical trials are still in early stages. There is currently NOT enough evidence to recommend methylene blue for treating these diseases.

Practical dosing

Goal	Dose	Frequency
Nootropic support	0.5–1 mg/kg body weight	Once daily, morning
Mitochondrial support	0.5–2 mg/kg	Once daily

For a 70 kg person: 35–70 mg per day for nootropic use.

The U-shaped dose-response curve

This is the single most important thing to understand about methylene blue: more is NOT better.

Low dose (0.5–2 mg/kg): Improves mitochondrial function, reduces oxidative stress, increases ATP production
High dose (>2 mg/kg): Increases oxidative stress, damages mitochondria, is toxic

This U-shaped response means dosing precision is critical. Always start with the lowest effective dose.

Safety and side effects

Common side effects:

Blue-coloured urine (normal and harmless)
Mild nausea on first use
Temporarily bluish lips/tongue

Serious risks:

Combining with SSRIs is PROHIBITED — risk of serotonin syndrome (potentially life-threatening) (Rodriguez et al., 2016)
People with G6PD deficiency (enzyme deficiency) — may cause haemolytic anaemia
Pregnant and breastfeeding women — not studied, do not use

Product quality

This is where you need to be especially careful. Methylene blue is not an ordinary supplement.

Require pharmaceutical-grade (USP) purity — technical grade contains heavy metals and other contaminants
Purity must be >98% — verified by a third party
Avoid "nootropic shop own-brand" products without certification

Common mistakes

1. Using technical grade instead of pharmaceutical grade. Technical methylene blue (dye) contains toxic impurities.
2. Taking too high a dose. The U-shaped curve means more = worse. Start at 0.5 mg/kg.
3. Combining with SSRIs. This is dangerous — serotonin syndrome is a medical emergency.
4. Expecting miracles from the first dose. Nootropic effects may develop over weeks.
5. Not expecting blue urine. This is completely normal — do not panic.

Frequently asked questions

Is methylene blue legal in Estonia?

Methylene blue is not a regulated medicine for supplement use in Estonia. It can be purchased from nootropic suppliers. However, finding high-quality sources is challenging.

Does it turn urine blue?

Yes, this is normal and safe. Urine may have a blue or green tinge for several hours after a dose.

Can methylene blue be combined with CoQ10?

Yes, both support mitochondrial function at different levels. CoQ10 acts as an electron carrier between Complexes II and III; methylene blue between Complexes I and IV.

Does methylene blue help with depression?

Preliminary studies point to MAO-inhibiting effects, but evidence is still early-stage. IMPORTANT: do not combine with antidepressants without medical supervision.

How long can methylene blue be used?

Long-term safety studies at nootropic doses are scarce. Cycling is recommended — 4–8 weeks on, 2–4 weeks off.

Estonia-specific notes

Interest in nootropics is growing in Estonia, especially among IT professionals and students. Methylene blue is a niche product, but its mitochondrial mechanism distinguishes it from typical nootropics. Long dark periods and limited sunlight (November–February) may increase the need for mitochondrial support.

You can find various nootropic supplements at MaxFit.ee.

References

1. Rojas, J.C., Bruchey, A.K. & Bhatt, D.L. (2012). Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy. Neurotoxicity Research, 21(1), 1–14.
2. Rodriguez, P., Singh, A.P., Malloy, K.E. & Liu, H. (2016). Methylene blue modulates functional connectivity in the human brain. NeuroImage, 142, 461–467.
3. Xiong, Z.M., O'Donovan, M., Sun, L., Bhatt, D. & Bhatt, D.L. (2017). Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria. Aging Cell, 16(6), 1400–1407.
4. Oz, M., Lorke, D.E. & Petroianu, G.A. (2011). Methylene blue and Alzheimer's disease. Biochemical Pharmacology, 82(11), 1588–1595.
5. Bruchey, A.K. & Bhatt, D.L. (2010). Methylene blue facilitates the extinction of fear in an animal model of susceptibility to learned helplessness. Neurobiology of Learning and Memory, 93(2), 231–237.

See also:

---

Disclaimer

This article is informational and does not replace medical advice. Methylene blue is not an ordinary supplement — consult your doctor before use, especially if taking medication.